Richter, Suzanne, et al. “Evaluation of Second Line and Subsequent Targeted Therapies in Metastatic Renal Cell Cancer (mRCC) Patients Treated With First Line Cediranib”. Canadian Urological Association Journal, vol. 8, no. 11-12, Dec. 2014, pp. 398-02, doi:10.5489/cuaj.2426.